Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Evolocumab> ?p ?o }
Showing triples 1 to 67 of
67
with 100 triples per page.
- Evolocumab abstract "Evolocumab (INN, trade name Repatha) is a monoclonal antibody designed for the treatment of hyperlipidemia by Amgen. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9).PCSK9 is a protein that targets LDL receptors for degradation and thereby reduces the liver's ability to remove LDL-C, or \"bad\" cholesterol, from the blood.Evolocumab is designed to bind to PCSK9 and inhibit PCSK9 from binding to LDL receptors on the liver surface. In the absence of PCSK9, there are more LDL receptors on the surface of the liver to remove LDL-C from the blood.".
- Evolocumab atcPrefix "C10".
- Evolocumab atcSuffix "AX13".
- Evolocumab casNumber "1256937-27-5".
- Evolocumab fdaUniiCode "LKC0U3A8NJ".
- Evolocumab wikiPageExternalLink repatha_pi_hcp_english.pdf.
- Evolocumab wikiPageID "39890836".
- Evolocumab wikiPageLength "4334".
- Evolocumab wikiPageOutDegree "13".
- Evolocumab wikiPageRevisionID "707383335".
- Evolocumab wikiPageWikiLink Amgen.
- Evolocumab wikiPageWikiLink Biologic_license_application.
- Evolocumab wikiPageWikiLink Category:Amgen.
- Evolocumab wikiPageWikiLink Category:PCSK9_inhibitor.
- Evolocumab wikiPageWikiLink Food_and_Drug_Administration.
- Evolocumab wikiPageWikiLink Hyperlipidemia.
- Evolocumab wikiPageWikiLink International_nonproprietary_name.
- Evolocumab wikiPageWikiLink LDL_receptor.
- Evolocumab wikiPageWikiLink Low-density_lipoprotein.
- Evolocumab wikiPageWikiLink Monoclonal_antibody.
- Evolocumab wikiPageWikiLink PCSK9.
- Evolocumab wikiPageWikiLink Subcutaneous_injection.
- Evolocumab wikiPageWikiLinkText "Evolocumab".
- Evolocumab wikiPageWikiLinkText "evolocumab".
- Evolocumab atcPrefix "10.0".
- Evolocumab atcSuffix "AX13".
- Evolocumab c "6242".
- Evolocumab casNumber "1256937".
- Evolocumab chemspiderid "none".
- Evolocumab h "9648".
- Evolocumab legalStatus "Rx-only".
- Evolocumab mabType "mab".
- Evolocumab molecularWeight "141.8".
- Evolocumab n "1668".
- Evolocumab o "1996".
- Evolocumab routesOfAdministration Subcutaneous_injection.
- Evolocumab s "56".
- Evolocumab source "u".
- Evolocumab synonyms "AMG-145".
- Evolocumab target PCSK9.
- Evolocumab tradename "Repatha".
- Evolocumab type "mab".
- Evolocumab unii "LKC0U3A8NJ".
- Evolocumab wikiPageUsesTemplate Template:Drugbox.
- Evolocumab wikiPageUsesTemplate Template:Fdacite.
- Evolocumab wikiPageUsesTemplate Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems.
- Evolocumab wikiPageUsesTemplate Template:Reflist.
- Evolocumab subject Category:Amgen.
- Evolocumab subject Category:PCSK9_inhibitor.
- Evolocumab hypernym Antibody.
- Evolocumab type ChemicalSubstance.
- Evolocumab type Drug.
- Evolocumab type ChemicalObject.
- Evolocumab type Thing.
- Evolocumab type Q8386.
- Evolocumab comment "Evolocumab (INN, trade name Repatha) is a monoclonal antibody designed for the treatment of hyperlipidemia by Amgen. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9).PCSK9 is a protein that targets LDL receptors for degradation and thereby reduces the liver's ability to remove LDL-C, or \"bad\" cholesterol, from the blood.Evolocumab is designed to bind to PCSK9 and inhibit PCSK9 from binding to LDL receptors on the liver surface.".
- Evolocumab label "Evolocumab".
- Evolocumab sameAs Q15623825.
- Evolocumab sameAs Evolocumab.
- Evolocumab sameAs Évolocumab.
- Evolocumab sameAs Evolocumab.
- Evolocumab sameAs エボロクマブ.
- Evolocumab sameAs Ewolokumab.
- Evolocumab sameAs m.0w7q9yh.
- Evolocumab sameAs Q15623825.
- Evolocumab wasDerivedFrom Evolocumab?oldid=707383335.
- Evolocumab isPrimaryTopicOf Evolocumab.